1. Home
  2. BXMT vs IOVA Comparison

BXMT vs IOVA Comparison

Compare BXMT & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackstone Mortgage Trust Inc.

BXMT

Blackstone Mortgage Trust Inc.

HOLD

Current Price

$13.91

Market Cap

2.5B

Sector

Real Estate

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$8.72

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BXMT
IOVA
Founded
1966
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
1.7B
IPO Year
1998
2008

Fundamental Metrics

Financial Performance
Metric
BXMT
IOVA
Price
$13.91
$8.72
Analyst Decision
Buy
Buy
Analyst Count
5
10
Target Price
$21.38
$9.00
AVG Volume (30 Days)
1.9M
14.2M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
9.85%
N/A
EPS Growth
154.70
14.84
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$47.74
Revenue Next Year
N/A
$40.31
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.61
$1.76
52 Week High
$20.67
$9.36

Technical Indicators

Market Signals
Indicator
BXMT
IOVA
Relative Strength Index (RSI) 36.98 68.07
Support Level $13.67 $3.57
Resistance Level $14.84 $9.36
Average True Range (ATR) 0.26 0.56
MACD 0.10 -0.03
Stochastic Oscillator 26.12 69.82

Price Performance

Historical Comparison
BXMT
IOVA

About BXMT Blackstone Mortgage Trust Inc.

Blackstone Mortgage Trust Inc is an externally managed real estate finance company that originates, acquires, and manages senior loans and other debt or credit-oriented investments collateralized by or relating to commercial real estate in North America, Europe, and Australia. Its portfolio is composed of senior loans secured by high-quality, institutional assets located in main markets, and sponsored by experienced, well-capitalized real estate investment owners and operators. The group finances its investments in a variety of ways, including borrowing under secured credit facilities, issuing collateralized loan obligations, or CLOs, other securitization transactions, syndicating senior loans and/or participations, and other forms of asset-level financing.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: